Previous 10 | Next 10 |
Usually, Once A Pattern Is Well Recognized It Stops Working I am hoping that I caught one before it really emerges. If we have, then we should generate good alpha. I believe I see the logic in it as well, just by examining my own "gut" over the course of the last few weeks. As we break i...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Investment Thesis PerkinElmer ( PKI ) maintains an attractive portfolio of analytical and diagnostic solutions for several industries. The name is 82 years old but the last ten years have majorly reshaped the firm. During this period the firm has significantly extended its portfolio by mak...
Agilent (NYSE: A ) initiated with Hold rating and $85 (11% upside) price target at Stifel. More news on: Agilent Technologies, Inc., Avantor, Inc., Bio-Techne Corporation, Healthcare stocks news, Stocks on the move, , Read more ...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel 2019 Healthcare Conference on Wednesday, November 20, 2019 at 11:30 a.m. ET at the Lotte New York Palace Hotel. Jamey Mock, senior vi...
Amarin (NASDAQ: AMRN ) initiated with with Buy rating at Aegis. Shares up 1% premarket. More news on: Tetraphase Pharmaceuticals, Inc., PerkinElmer, Inc., Amarin Corporation plc, Healthcare stocks news, Stocks on the move, , Read more ...
Image source: The Motley Fool. PerkinElmer Inc (NYSE: PKI) Q3 2019 Earnings Call Oct 30, 2019 , 5:00 p.m. ET Operator Continue reading
PerkinElmer, Inc. (PKI) Q3 2019 Earnings Conference Call October 30, 2019 5:00 PM ET Company Participants Bryan Kipp – Vice President-Investor Relations Rob Friel – Chairman and Chief Executive Officer Prahlad Singh – President and Chief Operating Officer J...
PerkinElmer (NYSE: PKI ) Q3 results : More news on: PerkinElmer, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...